Literature DB >> 29845532

Establishment and Application of Flavivirus Replicons.

Beate M Kümmerer1,2.   

Abstract

Dengue virus (DENV) and Zika virus (ZIKV) are enveloped, positive-strand RNA viruses belonging to the genus Flavivirus in the family Flaviviridae. The genome of ~11 kb length encodes one long open reading frame flanked by a 5' and a 3' untranslated region (UTR). The 5' end is capped and the 3' end lacks a poly(A) tail. The encoded single polyprotein is cleaved co-and posttranslationally by cellular and viral proteases. The first one-third of the genome encodes the structural proteins (C-prM-E), whereas the nonstructural (NS) proteins NS1-NS2A-NS3-NS4A-2K-NS4B-NS5 are encoded by the remaining two-thirds of the genome.Research on flaviviruses was driven forward by the ability to produce recombinant viruses using reverse genetics technology. It is known that the purified RNA of flaviviruses is per se infectious, which allows initiation of a complete viral life cycle by transfecting the genomic RNA into susceptible cells. In 1989, the first infectious flavivirus RNA was transcribed from full-length cDNA templates of yellow fever virus (YFV) facilitating molecular genetic analyses of this virus. In addition to the production of infectious recombinant viruses, reverse genetics can also be used to establish non-infectious replicons. Replicons contain an in-frame deletion in the structural protein genes but still encode all nonstructural proteins and contain the UTRs necessary to mediate efficient replication, a factor that enables their analyses under Biosafety Level (BSL) 1 conditions. This is particularly important since many flaviviruses are BSL3 agents.The review will cover strategies for generating flavivirus replicons, including the establishment of bacteriophage (T7 or SP6) promoter-driven constructs as well as cytomegalovirus (CMV) promoter-driven constructs. Furthermore, different reporter replicons or replicons expressing selectable marker proteins will be outlined using examples of their application to answer basic questions of the flavivirus replication cycle, to select and test antiviral compounds or to produce virus replicon particles. The establishment and application of flavivirus replicons will further be exemplified by my own data using an established YFV reporter replicon to study the role of YFV NS2A in the viral life cycle. In addition, we established a reporter replicon of a novel insect-specific flavivirus, namely Niénokoué virus (NIEV), to define the barrier(s) involved in host range restriction.

Entities:  

Keywords:  Flavivirus reverse genetics technology; Niénokoué virus; Non-infectious replicons; Selectable marker proteins; Yellow fever virus NS2A protein

Mesh:

Year:  2018        PMID: 29845532     DOI: 10.1007/978-981-10-8727-1_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  A fluorescence-activatable reporter of flavivirus NS2B-NS3 protease activity enables live imaging of infection in single cells and viral plaques.

Authors:  Jorge L Arias-Arias; Derek J MacPherson; Maureen E Hill; Jeanne A Hardy; Rodrigo Mora-Rodríguez
Journal:  J Biol Chem       Date:  2020-01-09       Impact factor: 5.157

2.  Model System for the Formation of Tick-Borne Encephalitis Virus Replication Compartments without Viral RNA Replication.

Authors:  Wai-Lok Yau; Van Nguyen-Dinh; Elin Larsson; Richard Lindqvist; Anna K Överby; Richard Lundmark
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

Review 3.  Zika Virus Pathogenesis: A Battle for Immune Evasion.

Authors:  Judith Estévez-Herrera; Silvia Pérez-Yanes; Romina Cabrera-Rodríguez; Daniel Márquez-Arce; Rodrigo Trujillo-González; José-David Machado; Ricardo Madrid; Agustín Valenzuela-Fernández
Journal:  Vaccines (Basel)       Date:  2021-03-22

Review 4.  Congenital Zika Syndrome: Genetic Avenues for Diagnosis and Therapy, Possible Management and Long-Term Outcomes.

Authors:  Giuseppe Gullo; Marco Scaglione; Gaspare Cucinella; Arianna Riva; Davide Coldebella; Anna Franca Cavaliere; Fabrizio Signore; Giovanni Buzzaccarini; Giulia Spagnol; Antonio Simone Laganà; Marco Noventa; Simona Zaami
Journal:  J Clin Med       Date:  2022-03-01       Impact factor: 4.241

5.  Generation and Implementation of Reporter BHK-21 Cells for Live Imaging of Flavivirus Infection.

Authors:  Jorge L Arias-Arias; Rodrigo Mora-Rodríguez
Journal:  Bio Protoc       Date:  2021-03-05

6.  LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination.

Authors:  Dingwen Hu; Yingchong Wang; Aixin Li; Qin Li; Caifeng Wu; Muhammad Adnan Shereen; Shanyu Huang; Kailang Wu; Ying Zhu; Wenbiao Wang; Jianguo Wu
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

Review 7.  Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus.

Authors:  Juan-Carlos Saiz; Nereida Jiménez de Oya; Ana-Belén Blázquez; Estela Escribano-Romero; Miguel A Martín-Acebes
Journal:  Viruses       Date:  2018-08-24       Impact factor: 5.048

Review 8.  Research Models and Tools for the Identification of Antivirals and Therapeutics against Zika Virus Infection.

Authors:  Marco P Alves; Nathalie J Vielle; Volker Thiel; Stephanie Pfaender
Journal:  Viruses       Date:  2018-10-30       Impact factor: 5.048

Review 9.  Flavivirus: From Structure to Therapeutics Development.

Authors:  Rong Zhao; Meiyue Wang; Jing Cao; Jing Shen; Xin Zhou; Deping Wang; Jimin Cao
Journal:  Life (Basel)       Date:  2021-06-25

Review 10.  Construction of Stable Reporter Flaviviruses and Their Applications.

Authors:  Coleman Baker; Pei-Yong Shi
Journal:  Viruses       Date:  2020-09-25       Impact factor: 5.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.